Eptazocine hydrobromide Injection(Chengdu Easton Biopharma)

氢溴酸依他佐辛注射液(成都苑东生物制药)

Report date: 2025/08/01 15:52:30

Base Information

Drug NameEptazocine hydrobromide Injection(Chengdu Easton Biopharma)
Drug Alias Name氢溴酸依他佐辛注射液(2.2类改良型)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor antagonistsKappa opioid receptor agonists
TargetsMu opioid receptorKappa opioid receptor
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG